119 related articles for article (PubMed ID: 30412988)
1. Re: AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women with Overactive Bladder.
Wein AJ
J Urol; 2018 Sep; 200(3):503-504. PubMed ID: 30412988
[No Abstract] [Full Text] [Related]
2. AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
This document was developed by the American Urogynecologic Society (AUGS) Guidelines Committee with the assistance of Tonya N. Thomas, MD, and Mark D. Walters, MD. This document reflects clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Its content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient.
Female Pelvic Med Reconstr Surg; 2017; 23(3):177-178. PubMed ID: 28441276
[TBL] [Abstract][Full Text] [Related]
3. Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder.
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):69-71. PubMed ID: 33497068
[TBL] [Abstract][Full Text] [Related]
4. Re: Is Self-Reported Adherence Associated with Clinical Outcomes in Women Treated with Anticholinergic Medication for Overactive Bladder?
Wein AJ
J Urol; 2017 Jun; 197(6):1525-1526. PubMed ID: 28505920
[No Abstract] [Full Text] [Related]
5. Re: Andy UU, Arya LA, Smith AL, et al. Is self-reported adherence associated with clinical outcomes in women treated with anticholinergic medication for overactive bladder?. Neurourol Urodyn 2016;35:738-42.
Averbeck MA
Neurourol Urodyn; 2016 Sep; 35(7):856. PubMed ID: 25995164
[No Abstract] [Full Text] [Related]
6. Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
Lee KS; Lee HW; Han DH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):491-501. PubMed ID: 18172610
[TBL] [Abstract][Full Text] [Related]
7. Re: Comparing Anticholinergic Persistence and Adherence Profiles in Overactive Bladder Patients Based on Gender, Obesity, and Major Anticholinergic Agents.
Wein AJ
J Urol; 2018 Nov; 200(5):948-951. PubMed ID: 30360348
[No Abstract] [Full Text] [Related]
8. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
Kerdraon J; Robain G; Jeandel C; Mongiat Artus P; Gamé X; Fatton B; Scheiber-Nogueira MC; Vetel JM; Mares P; Petit AC; Amarenco G;
Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
[TBL] [Abstract][Full Text] [Related]
9. Re: Impact of Anticholinergic Load on Bladder Function.
Griebling TL
J Urol; 2017 May; 197(5):1319-1320. PubMed ID: 29539929
[No Abstract] [Full Text] [Related]
10. Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
Chancellor MB; Yehoshua A; Waweru C; Globe D; Cheng IN; Campbell KL; Joshi M; Pulicharam R
Int Urol Nephrol; 2016 Jul; 48(7):1029-36. PubMed ID: 27032397
[TBL] [Abstract][Full Text] [Related]
11. Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients.
Krhut J; Gärtner M; Petzel M; Sykora R; Nemec D; Tvrdik J; Skoupa J
Scand J Urol; 2014 Feb; 48(1):79-83. PubMed ID: 23870042
[TBL] [Abstract][Full Text] [Related]
12. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
13. Use of anticholinergic therapy in men.
Bauer R; Kaufman R; Mian BM
Can J Urol; 2008 Dec; 15(6):4359-62. PubMed ID: 19046488
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults.
Roxburgh C; Cook J; Dublin N
Cochrane Database Syst Rev; 2007 Jul; (3):CD003190. PubMed ID: 17636716
[TBL] [Abstract][Full Text] [Related]
15. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.
Chancellor MB; Migliaccio-Walle K; Bramley TJ; Chaudhari SL; Corbell C; Globe D
Clin Ther; 2013 Nov; 35(11):1744-51. PubMed ID: 24091072
[TBL] [Abstract][Full Text] [Related]
16. Re: Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.
Wein AJ
J Urol; 2013 Nov; 190(5):1815-6. PubMed ID: 24120792
[No Abstract] [Full Text] [Related]
17. Nonpharmacologic vs. anticholinergic therapies for overactive bladder.
Kripke C
Am Fam Physician; 2007 May; 75(9):1336. PubMed ID: 17508527
[No Abstract] [Full Text] [Related]
18. [Idiopathic overactive bladder: What to do in case of anticholinergic failure?].
Boudy AS; Thubert T
Prog Urol; 2015 Jun; 25(8):497-8. PubMed ID: 25748787
[No Abstract] [Full Text] [Related]
19. Drug therapy for an overactive bladder.
Thiagamoorthy G; Cardozo L; Srikrishna S
Womens Health (Lond); 2015 Jul; 11(4):445-8. PubMed ID: 26238677
[No Abstract] [Full Text] [Related]
20. Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.
Mauseth SA; Skurtveit S; Spigset O
Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1208-15. PubMed ID: 23763552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
